B Braun Medical Company Profile

✉ Email this page to a colleague

B BRAUN MEDICAL has sixteen approved drugs.

There are three US patents protecting B BRAUN MEDICAL drugs.

There are fifty patent family members on B BRAUN MEDICAL drugs in twenty-nine countries and seventy-six supplementary protection certificates in sixteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun Medical	LIDOCAINE HYDROCHLORIDE	lidocaine hydrochloride	INJECTABLE;INJECTION	208474-001	Aug 3, 2018	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
B Braun Medical	MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	meropenem	POWDER;INTRAVENOUS	202106-002	Apr 30, 2015		RX	No	No		⤷ Start Trial				⤷ Start Trial
B Braun Medical	PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	piperacillin sodium; tazobactam sodium	POWDER;INTRAVENOUS	206056-002	Apr 3, 2025		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
B Braun Medical	LEVETIRACETAM IN SODIUM CHLORIDE	levetiracetam	INJECTABLE;INTRAVENOUS	209705-001	Feb 27, 2024	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
B Braun Medical	ACETAMINOPHEN	acetaminophen	SOLUTION;INTRAVENOUS	204957-001	Feb 18, 2021	AP	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
B Braun Medical	PIPERACILLIN AND TAZOBACTAM AND SODIUM CHLORIDE IN DUPLEX CONTAINER	piperacillin sodium; tazobactam sodium	POWDER;INTRAVENOUS	206056-001	Apr 3, 2025		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Malaysia	180957	⤷ Start Trial
Russian Federation	2015128024	⤷ Start Trial
Poland	1931304	⤷ Start Trial
Italy	MI20051633	⤷ Start Trial
Israel	236042	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2007028788	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2603514	1990017-4	Sweden	⤷ Start Trial	PRODUCT NAME: A COMBINATION OF VABORBACTAM AND/OR SALT OR HYDRATE THEREOF, AND MEROPENEM AND/OR A SALT HYDRATE THEREOF, IN PARTICULAR MEROPENEM TRIHYDRATE.; REG. NO/DATE: EU/1/18/1334 20181122
0247633	62/1997	Austria	⤷ Start Trial	PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
3412676	PA2020519	Lithuania	⤷ Start Trial	PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120
2365988	2018C/006	Belgium	⤷ Start Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM OF EERDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721
2365988	122018000012	Germany	⤷ Start Trial	PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
1499331	13C0055	France	⤷ Start Trial	PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: BE - 434323 20130220
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.